NUMBER OF AIM SECURITIES IN ISSUE
As of 28 January 2025, the number of shares in issue was 533,352,523.
SIGNIFICANT SHAREHOLDERS
As of 21 December 2024, significant shareholdings in the share capital of Eden Research plc were:
Name
Number of shares
% of the issued ordinary share capital
Hargreaves Lansdown
56,608,629
10.61%
Gresham House Asset Management Limited
52,882,786
9.92%
Interactive Investor
44,756,732
8.39%
Octopus Investments
41,551,047
7.79%
Sipcam Oxon S.p.A.
39,285,138
7.37%
Canaccord Genuity Wealth Management
30,201,307
5.66%
Atul Unadkat
23,486,291
4.40%
Unicorn Asset Management
23,076,923
4.33%
J M Finn
22,381,562
4.20%
Rathbones
21,567,400
4.04%
Amati Global Investors
16,744,070
3.14%
As of 28 January 2025, the directors' shareholdings in the share capital of Eden Research plc were:
Name
Number of shares
% of the issued ordinary share capital
A Abrey
2,314,732
0.43%
S Smith
1,913,117
0.36%
L van der Broek
1,621,808
0.30%
R Cridland
745,552
0.14%
D McAllan
323,017
0.11% |
 Alchemy
We do know something.
Down Mildew regulatory approval due, same with Eu wide Ecovelex and partnerships for distribution of our insecticide to be confirmed. Three huge announcements for Eden and future recurring revenue, thus delivering profits. I sound like a parrot, I know.
Never had a regulatory submission rejected, so highly unlikely they will now.
Same 3 active ingredients being used and already has mass approval
Same Sustaine with mass approval.
Someone is a chosen/forced seller. BGF?! Once that restrictive path to an increasing price has passed, we should all be a bit happier. That said, it is going to take more than that.
Cavendish has had a price target of 20p for how long? At least one year plus, so why the big chasm between value and price today? That needs to be sorted which may also warrant an assessment on the contribution of Cavendish in this respect.
If we are worth 20p today, where does that value lie and why is Hawthorn not getting that story into the mainstream press targeting private investors specifically.
All parties involved in Eden need to be less Rachel Reeves and more Donald Trump. Let's start talking about opportunity, showcasing value, spelling it out explicitly, exciting investors and hopefully a change in that communication will help to stir up investment through understanding the value of 3 pending SUPER announcements. |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
